Log In
BCIQ
Print this Print this
 

CD79b molecule immunoglobulin-associated beta (CD79B) (B29)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD79b molecule immunoglobulin-associated beta (CD79B) (B29)

BCIQ
Print ChartPrint this
0 0 1 1 1 0
Phases of DevelopmentPreclinicalPhase IPhase II
Autoimmune

1

1

0

Cancer

0

0

1




 Products Targeting CD79b molecule immunoglobulin-associated beta (CD79B) (B29)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$501.5M

0

$468.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today